1 |
Ao Y, Wang Z, Hu J, Yao M, Zhang W. Identification of essential genes and immune cell infiltration in rheumatoid arthritis by bioinformatics analysis. Sci Rep 2023;13:2032. [PMID: 36739468 DOI: 10.1038/s41598-023-29153-3] [Reference Citation Analysis]
|
2 |
Zhang Q, Xie Z, Li Y, Zhu Q, Shi H, Zhao R, Yang X, Tian J, Ma L. The potential of Lycium barbarum miR166a in kidney cancer treatment. Exp Cell Res 2023;423:113455. [PMID: 36584744 DOI: 10.1016/j.yexcr.2022.113455] [Reference Citation Analysis]
|
3 |
Kocher F, Puccini A, Untergasser G, Martowicz A, Zimmer K, Pircher A, Baca Y, Xiu J, Haybaeck J, Tymoszuk P, Goldberg RM, Petrillo A, Shields AF, Salem ME, Marshall JL, Hall M, Korn WM, Nabhan C, Battaglin F, Lenz HJ, Lou E, Choo SP, Toh CK, Gasteiger S, Pichler R, Wolf D, Seeber A. Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. Clin Cancer Res 2022;28:4957-67. [PMID: 36112544 DOI: 10.1158/1078-0432.CCR-22-0275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Puccini A, Seeber A, Berger MD. Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective. Cancers 2022;14:4828. [DOI: 10.3390/cancers14194828] [Reference Citation Analysis]
|
5 |
Li C, Chen S, Liu C, Mo C, Gong W, Hu J, He M, Xie L, Hou X, Tang J, Ou M. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Hereditas 2022;159:37. [PMID: 36167571 DOI: 10.1186/s41065-022-00251-y] [Reference Citation Analysis]
|
6 |
Zhao Y, Bai Y, Shen M, Li Y. Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Front Immunol 2022;13:992762. [DOI: 10.3389/fimmu.2022.992762] [Reference Citation Analysis]
|
7 |
Ao Y, Wang Z, Hu J, Yao M, Zhang W. Identification of essential genes and immune cell infiltration in rheumatoid arthritis by bioinformatics analysis.. [DOI: 10.21203/rs.3.rs-2054999/v1] [Reference Citation Analysis]
|
8 |
Radanovic I, Klarenbeek N, Rissmann R, Groeneveld GJ, van Brummelen EMJ, Moerland M, Bosch JJ. Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds. Front Oncol 2022;12:954806. [DOI: 10.3389/fonc.2022.954806] [Reference Citation Analysis]
|
9 |
Wang F, Tao Z, Tian Z, Jin J, Dong J, Dai Y, Yu W, Tang B, Hu S. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment. Front Genet 2022;13:874896. [DOI: 10.3389/fgene.2022.874896] [Reference Citation Analysis]
|
10 |
Ran GH, Lin YQ, Tian L, Zhang T, Yan DM, Yu JH, Deng YC. Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduct Target Ther 2022;7:205. [PMID: 35768424 DOI: 10.1038/s41392-022-01058-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 18.0] [Reference Citation Analysis]
|
11 |
Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MedComm (2020) 2022;3:e147. [PMID: 35702353 DOI: 10.1002/mco2.147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
12 |
Raghavakaimal A, Cristofanilli M, Tang C, Alpaugh RK, Gardner KP, Chumsri S, Adams DL. CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome. Breast Cancer Res 2022;24. [DOI: 10.1186/s13058-022-01528-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
13 |
Münz C. Natural Killer Cell Responses during Human γ-Herpesvirus Infections. Vaccines (Basel) 2021;9:655. [PMID: 34203904 DOI: 10.3390/vaccines9060655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
14 |
Qiu Y, Cao Y, Tu G, Li J, Su Y, Fang F, Zhang X, Cang J, Rong R, Luo Z. Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis. Front Immunol 2021;12:698894. [PMID: 34566958 DOI: 10.3389/fimmu.2021.698894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|